NCT02337530 2024-03-21Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLCCanadian Cancer Trials GroupPhase 2 Completed62 enrolled 13 charts